UBC study seeks to interview those who have taken part in a trial of a prescription drug
Many trials are never published, and researchers would like to hear what trial participants think about it
Clinical trials are essential for developing new drugs and providing the best medical care. However, about 4 in every 10 clinical trials are either not published or only published after a long delay. When clinical trials remain unpublished, the results are unavailable to the wider scientific community. This makes it more difficult for the researchers, doctors and others to know which drugs are safe and effective.
Why participate in this interview study?
Patients play a key role in research as participants in clinical trials, and learning about the trials from the patient perspective is important to improving medical research. We are interested to learn more about the experiences and views of people who have taken part in a clinical trial of a prescription drug. As part of the study, we would like find out how trial participants view the importance of publishing the results of trial
You may be eligible to participate in this study if:
- You participated in a clinical trial of a prescription drug in Canada within the last 5 years and your participation ended prior to the last 12 months.
- You participated as a patient with a medical condition, rather than as a ‘healthy volunteer.’
- You were 18 years or older when you participated in the trial.
Participating will involve taking part in an interview of about 60 to 90 minutes and possibly a 30-minute follow-up interview. Interviews will be held in Victoria or Vancouver. Participants will receive a $50 honorarium for their time
To volunteer or find out more
Those interested in participating or finding out more information about the Inside Trials Study can contact co-Investigator Richard Morrow at firstname.lastname@example.org. The Principal Investigator of the study is Dr. Colin Dormuth, Associate Professor, Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia.
Additional information about the study
The study will also involve interviews with clinical trial investigators, university administrators and research ethics board members to provide additional perspectives on clinical trials and trial reporting. The study will be conducted for a doctoral thesis. Measures will be taken to protect the confidentiality of information provided during interviews for this study.